Sg2 Senior Consulting Director Amanda Olderog shared four additional projections for GI and urology over the next decade in ASC Focus:
1. Direct-to-consumer, stool-based screening tests such as Cologuard will contribute to a spike in GI diagnostic service volumes.
2. Rising diagnostic service volumes for GI will also be driven by heightened awareness of early-onset colorectal cancer.
3. Improvements in minimally invasive and noninvasive treatments will push more urology services to outpatient settings.
4. Overall demand for urological services is expected to increase as the U.S. population ages.
Click here to read more.
More articles on gastroenterology:
RedHill Biopharma terminates agreement with Salix & more: 6 GI industry key notes
ConMed wins $36M defense contract
What the GI specialty will look like in 10 years & 4 other must-read articles
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.